181 related articles for article (PubMed ID: 34348636)
1. Structural Activity Relationship based Medicinal Perspectives of Pyrimidine Derivatives as Anti-Alzheimer's Agents: A Comprehensive Review.
Das S; Akbar S; Ahmed B; Dewangan RP; Iqubal A; Pottoo FH; Joseph A
CNS Neurol Disord Drug Targets; 2022; 21(10):926-939. PubMed ID: 34348636
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships of Pyrimidine Derivatives and their Biological Activity - A Review.
Natarajan R; Anthoni Samy HN; Sivaperuman A; Subramani A
Med Chem; 2022; 19(1):10-30. PubMed ID: 35579151
[TBL] [Abstract][Full Text] [Related]
3. Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents.
Abbas N; Matada GSP; Dhiwar PS; Patel S; Devasahayam G
Anticancer Agents Med Chem; 2021; 21(7):861-893. PubMed ID: 32698738
[TBL] [Abstract][Full Text] [Related]
4. Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes.
Joshi G; Nayyar H; Alex JM; Vishwakarma GS; Mittal S; Kumar R
Curr Top Med Chem; 2016; 16(28):3175-3210. PubMed ID: 27150371
[TBL] [Abstract][Full Text] [Related]
5. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
Nehra B; Mathew B; Chawla PA
Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
[TBL] [Abstract][Full Text] [Related]
6. An Overview on Synthetic and Medicinal Perspectives of [1,2,4]Triazolo[1,5-a]pyrimidine Scaffold.
Merugu SR; Cherukupalli S; Karpoormath R
Chem Biodivers; 2022 Sep; 19(9):e202200291. PubMed ID: 35946991
[TBL] [Abstract][Full Text] [Related]
7. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
8. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
9. An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents.
Rani I; Kaur N; Goyal A; Sharma M
Anticancer Agents Med Chem; 2023; 23(5):525-561. PubMed ID: 35786337
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
[TBL] [Abstract][Full Text] [Related]
11. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Cherukupalli S; Karpoormath R; Chandrasekaran B; Hampannavar GA; Thapliyal N; Palakollu VN
Eur J Med Chem; 2017 Jan; 126():298-352. PubMed ID: 27894044
[TBL] [Abstract][Full Text] [Related]
12. Recent medicinal approaches of novel pyrimidine analogs: A review.
Patil SB
Heliyon; 2023 Jun; 9(6):e16773. PubMed ID: 37346348
[TBL] [Abstract][Full Text] [Related]
13. Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study.
Zhang L; Xin M; Shen H; Wen J; Tang F; Tu C; Zhao X; Wei P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3486-92. PubMed ID: 24923765
[TBL] [Abstract][Full Text] [Related]
14. Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective.
Grover P; Rohilla S; Bhardwaj M; Mehta L; Malhotra A
Curr Top Med Chem; 2023; 23(13):1221-1259. PubMed ID: 37038678
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety.
Shaaban MR; Saleh TS; Mayhoub AS; Mansour A; Farag AM
Bioorg Med Chem; 2008 Jun; 16(12):6344-52. PubMed ID: 18502132
[TBL] [Abstract][Full Text] [Related]
16. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
17. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review.
Kumar A; Siwach A; Verma P
Mini Rev Med Chem; 2022; 22(6):884-903. PubMed ID: 34629043
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.
Pathania S; Rawal RK
Eur J Med Chem; 2018 Sep; 157():503-526. PubMed ID: 30114661
[TBL] [Abstract][Full Text] [Related]
19. Recent Development of Pyrimidine-Containing Antimicrobial Agents.
Zhuang J; Ma S
ChemMedChem; 2020 Oct; 15(20):1875-1886. PubMed ID: 32797654
[TBL] [Abstract][Full Text] [Related]
20. Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity.
Nadar S; Khan T
Chem Biol Drug Des; 2022 Dec; 100(6):818-842. PubMed ID: 34914188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
